Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Case Reports in Immunology
Volume 2017, Article ID 4249157, 3 pages
https://doi.org/10.1155/2017/4249157
Case Report

Docetaxel-Induced Systemic Sclerosis with Internal Organ Involvement Masquerading as Congestive Heart Failure

Department of Family Medicine, Henry Ford Hospital, Wayne State University School of Medicine, Detroit, MI 48202, USA

Correspondence should be addressed to Bumsoo Park; gro.shfh@1krapb

Received 2 November 2016; Revised 9 January 2017; Accepted 22 January 2017; Published 6 February 2017

Academic Editor: Necil Kütükçüler

Copyright © 2017 Bumsoo Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. A. Wollheim, “Classification of systemic sclerosis. Visions and reality,” Rheumatology, vol. 44, no. 10, pp. 1212–1216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. F. van den Hoogen, D. Khanna, J. Fransen et al., “2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Arthritis & Rheumatism, vol. 65, no. 11, pp. 2737–2747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Chew and V. S. L. Chuen, “Cutaneous reaction associated with weekly docetaxel administration,” Journal of Oncology Pharmacy Practice, vol. 15, no. 1, pp. 29–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. F. Battafarano, G. C. Zimmerman, S. A. Older, J. H. Keeling, and H. A. Burris, “Docetaxel (taxotere) associated scleroderma-like changes of the lower extremities: a report of three cases,” Cancer, vol. 76, no. 1, pp. 110–115, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Vignes and B. Lebrun-Vignes, “Sclerodermiform aspect of arm lymphoedema after treatment with docetaxel for breast cancer,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 8, pp. 1131–1133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Bouchard, M. R. Mohr, and R. J. Pariser, “Taxane-induced morphea in a patient with CREST syndrome,” Dermatology Reports, vol. 2, no. 1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Cleveland, B. S. Ajaikumar, and R. Reganti, “Cutaneous fibrosis induced by docetaxel: a case report,” Cancer, vol. 88, no. 5, pp. 1078–1081, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Hassett, P. Harnett, and N. Manolios, “Scleroderma in association with the use of docetaxel (taxotere) for breast cancer,” Clinical and Experimental Rheumatology, vol. 19, no. 2, pp. 197–200, 2001. View at Google Scholar · View at Scopus
  9. T. N. Wight, M. G. Kinsella, S. P. Evanko, S. Potter-Perigo, and M. J. Merrilees, “Versican and the regulation of cell phenotype in disease,” Biochimica et Biophysica Acta—General Subjects, vol. 1840, no. 8, pp. 2441–2451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Hesselstrand, G. Westergren-Thorsson, A. Scheja, M. Wildt, and A. Åkesson, “The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis,” Clinical and Experimental Rheumatology, vol. 20, no. 3, pp. 301–308, 2002. View at Google Scholar · View at Scopus
  11. K. Okada, Y. Endo, Y. Miyachi, Y. Koike, Y. Kuwatsuka, and A. Utani, “Glycosaminoglycan and versican deposits in taxane-induced sclerosis,” British Journal of Dermatology, vol. 173, no. 4, pp. 1054–1058, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-H. Hung, S.-H. Chan, P.-M. Chu, and K.-L. Tsai, “Docetaxel facilitates endothelial dysfunction through oxidative stress via modulation of protein kinase C beta: the protective effects of sotrastaurin,” Toxicological Sciences, vol. 145, no. 1, pp. 59–67, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. C. G. Joseph, E. Darrah, A. A. Shah et al., “Association of the autoimmune disease scleroderma with an immunologic response to cancer,” Science, vol. 343, no. 6167, pp. 152–157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. B. M. Reilly, “Physical examination in the care of medical inpatients: An Observational Study,” Lancet, vol. 362, no. 9390, pp. 1100–1105, 2003. View at Publisher · View at Google Scholar · View at Scopus